First FDA-Approved Treatment for ALS in 22 Years Now Available in U.S
Mitsubishi Tanabe Pharma America, Inc. announced RADICAVA ™ (edaravone), an intravenous therapy indicated for all adult patients diagnosed with amyotrophic lateral sclerosis...
FDA Approval Of CaroSpir Announced By CMP Pharma , Inc.
CMP Pharma announced that the US FDA has granted final approval of the company’s NDA for CaroSpir® (Spironolactone Oral Suspension,...
Takeda and Molecular templates announce research and collaboration to develop next-generation oncology therapies
Takeda Pharma and Molecular Templates, Inc. announced a collaboration agreement for oncology drug discovery programs. The collaboration will apply Molecular...
Bristol-Myers Squibb acquires IFM Therapeutics
BMS Company and IFM Therapeutics announced that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire...
Intercept Announces Phase 2 AESOP Trial Evaluating OCA for the Treatment of Patients with PSC
Intercept Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral...
The Emmes Corporation Wins $70 Million Contract for Pediatric Research
The Emmes Corporation announced that it was awarded a contract from the National Institutes of Health to support pediatric clinical...
X4 Pharmaceuticals Announces Rare Disease Research Collaboration with Yale University
X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 inhibitor drugs to improve immune cell trafficking to treat...
EC Grants AbbVie’s MAVIRET Marketing Authorization for the Treatment of Chronic Hepatitis C
AbbVie , a global biopharmaceutical company announced that the EC has granted marketing authorization for MAVIRET® (glecaprevir/pibrentasvir), a once-daily, ribavirin-free...
Teva and Xenon Announce Phase II Study of Topical TV-45070
Teva Pharmaceutical Industries Ltd. and Xenon Pharmaceuticals Inc. announce top-line results in a Phase II study of topical TV-45070 in...
Novo Nordisk says Victoza has been approved in EU
The EC has approved an update to the Victoza® (liraglutide) EU label that expands the indication to reflect both improving...
Latest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.